title: Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation.
abstract: Inflammation arises in the CNS from a number of neurodegenerative and oncogenic disorders, as well as from ischemic and traumatic brain injuries. These pathologies give rise to increased levels of extracellular adenine nucleotides which, via activation of a variety of cell surface P2 purinergic receptors, influence the inflammatory activities of responding immune cells. One P2 receptor subtype in particular, the P2X(7) receptor, potentiates the release of pro-inflammatory cytokines, such as interleukin-1beta (IL-1beta) from macrophage-like cells. It is also thought to contribute to secondary brain injury by inducing neuronal cell death. Therefore, antagonism of this receptor could have significant therapeutic impact on all disorders, not just CNS, to which excessive inflammatory activities contribute. The use of currently available P2X(7) receptor antagonists for the treatment of CNS inflammation has been limited to the generally non-selective antagonists PPADS, oxidized ATP, Brilliant Blue G, suramin, calmidizolium, and KN-62. However, the recent patents and development of novel P2X(7) receptor antagonists, as discussed in this review, will provide new tools both for clinical and research purposes. Here we discuss compounds for which patents have been applied since 2006, from the following categories: benzamide inhibitors, bicycloheteroaryl compounds, acylhdranzine antagonists, biaromatic P2X(7) antagonists, heterocyclic compounds and amide derivatives, and aromatic amine antagonists.
authors.affiliation: Program in Cellular and Molecular Biology and Department of Comparative Biosciences, University of Wisconsin, Madison, WI 53706, USA.
authors.forename: Scott A
authors.initials: SA
authors.lastname: Friedle
authors.forename: Marjorie A
authors.initials: MA
authors.lastname: Curet
authors.forename: Jyoti J
authors.initials: JJ
authors.lastname: Watters
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000737:chemistry / Q000627:therapeutic use*; D004660:Encephalitis / Q000188:drug therapy*; D006801:Humans; D009187:Myelitis / Q000188:drug therapy*; D010330:Patents as Topic; D058919:Purinergic P2 Receptor Antagonists; D018048:Receptors, Purinergic P2 / Q000378:metabolism; D058486:Receptors, Purinergic P2X7
chemical_list: D000893:Anti-Inflammatory Agents; C546468:P2RX7 protein, human; D058919:Purinergic P2 Receptor Antagonists; D018048:Receptors, Purinergic P2; D058486:Receptors, Purinergic P2X7
references.citation: J Biol Chem. 2009 Jul 3;284(27):18143-51
references.pmid: 19416975
references.citation: BMC Cancer. 2006 Sep 23;6:226
references.pmid: 16995949
references.citation: Exp Mol Med. 2007 Dec 31;39(6):820-7
references.pmid: 18160853
references.citation: Proc Natl Acad Sci U S A. 2009 May 12;106(19):8032-7
references.pmid: 19380717
references.citation: Arch Biochem Biophys. 1990 Aug 1;280(2):263-8
references.pmid: 2369117
references.citation: J Biol Chem. 2005 Sep 16;280(37):32459-67
references.pmid: 16030017
references.citation: J Med Chem. 2008 May 22;51(10):3030-4
references.pmid: 18438986
references.citation: Curr Biol. 2000 Apr 20;10(8):R305-7
references.pmid: 10801405
references.citation: Med Sci Monit. 2001 Jul-Aug;7(4):669-74
references.pmid: 11433193
references.citation: J Biol Chem. 2007 Jan 26;282(4):2386-94
references.pmid: 17121814
references.citation: Neuropharmacology. 1997 Sep;36(9):1295-301
references.pmid: 9364484
references.citation: J Mol Cell Cardiol. 2005 Dec;39(6):929-39
references.pmid: 16242142
references.citation: Neuroscience. 2009 Feb 6;158(3):1122-32
references.pmid: 18848864
references.citation: J Neurosci. 2000 Apr 15;20(8):2835-44
references.pmid: 10751435
references.citation: Am J Physiol. 1999 Jan;276(1):C267-78
references.pmid: 9886943
references.citation: Pharmacol Rev. 2001 Mar;53(1):107-18
references.pmid: 11171941
references.citation: J Biol Chem. 2009 May 15;284(20):13446-13454
references.pmid: 19304656
references.citation: Biomed Pharmacother. 1989;43(10):727-36
references.pmid: 2701287
references.citation: J Neurochem. 2008 Jul;106(1):271-80
references.pmid: 18384650
references.citation: Am J Physiol Renal Physiol. 2002 Apr;282(4):F763-75
references.pmid: 11880338
references.citation: Br J Pharmacol. 1994 Jul;112(3):946-50
references.pmid: 7921625
references.citation: Cancer Res. 2006 Jan 15;66(2):907-14
references.pmid: 16424024
references.citation: Annu Rev Physiol. 2009;71:333-59
references.pmid: 18851707
references.citation: Cancer Lett. 2003 Aug 20;198(2):211-8
references.pmid: 12957360
references.citation: J Comp Neurol. 2008 Jan 1;506(1):75-92
references.pmid: 17990272
references.citation: Curr Drug Targets CNS Neurol Disord. 2003 Dec;2(6):403-12
references.pmid: 14683468
references.citation: BMC Neurol. 2006 Mar 02;6:12
references.pmid: 16512913
references.citation: PLoS One. 2008 Jul 09;3(7):e2599
references.pmid: 18612415
references.citation: Expert Opin Ther Targets. 2008 May;12(5):647-61
references.pmid: 18410246
references.citation: J Neurosci. 1998 Nov 1;18(21):8794-804
references.pmid: 9786986
references.citation: J Neurosci. 2007 Aug 29;27(35):9525-33
references.pmid: 17728465
references.citation: J Med Chem. 2009 May 28;52(10):3123-41
references.pmid: 19191585
references.citation: J Immunol. 2006 Apr 1;176(7):3877-83
references.pmid: 16547218
references.citation: Neuroreport. 1996 Nov 4;7(15-17):2533-7
references.pmid: 8981418
references.citation: Neuroscience. 2005;134(1):199-205
references.pmid: 15964696
references.citation: J Immunol. 2000 Oct 15;165(8):4615-23
references.pmid: 11035104
references.citation: J Cell Physiol. 2006 Oct;209(1):172-82
references.pmid: 16826604
references.citation: Glia. 2005 Jan 15;49(2):245-58
references.pmid: 15472991
references.citation: Neurosci Lett. 1999 Jul 23;270(1):25-8
references.pmid: 10454137
references.citation: J Immunol. 1996 Feb 15;156(4):1531-9
references.pmid: 8568257
references.citation: J Biol Chem. 1987 Mar 5;262(7):3118-22
references.pmid: 2950094
references.citation: J Physiol. 1996 Nov 15;497 ( Pt 1):53-66
references.pmid: 8951711
references.citation: Am J Physiol Cell Physiol. 2001 Jan;280(1):C81-9
references.pmid: 11121379
references.citation: Pharmacology. 2000 Feb;60(2):105-12
references.pmid: 10657760
references.citation: Cell Death Differ. 1998 Mar;5(3):191-9
references.pmid: 10200464
references.citation: Neurobiol Dis. 2007 Jan;25(1):8-16
references.pmid: 17045808
references.citation: J Neurosci. 2007 May 2;27(18):4957-68
references.pmid: 17475804
references.citation: Br J Pharmacol. 2007 Jul;151(5):571-9
references.pmid: 17471177
references.citation: Immunity. 2003 Sep;19(3):403-12
references.pmid: 14499115
references.citation: Mol Pharmacol. 2000 Jul;58(1):82-8
references.pmid: 10860929
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2006 Jun 5;141B(4):374-82
references.pmid: 16673375
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15735-40
references.pmid: 9861039
references.citation: Pharmacol Rev. 1998 Sep;50(3):413-92
references.pmid: 9755289
references.citation: Eur J Pharmacol. 2002 Jul 5;447(2-3):261-9
references.pmid: 12151017
references.citation: Physiol Rev. 2007 Apr;87(2):659-797
references.pmid: 17429044
references.citation: Trends Neurosci. 2006 May;29(5):257-62
references.pmid: 16564580
references.citation: J Neuroimmunol. 2004 Feb;147(1-2):56-61
references.pmid: 14741428
references.citation: J Biol Chem. 1990 Mar 15;265(8):4315-20
references.pmid: 2155222
references.citation: Mol Pharmacol. 1995 Aug;48(2):178-83
references.pmid: 7544432
references.citation: Mol Pharmacol. 2007 Dec;72(6):1447-56
references.pmid: 17785580
references.citation: Curr Mol Med. 2009 Mar;9(2):186-94
references.pmid: 19275626
references.citation: J Cell Biochem. 1995 Mar;57(3):452-64
references.pmid: 7768980
references.citation: J Pharmacol Exp Ther. 2006 Dec;319(3):1376-85
references.pmid: 16982702
references.citation: BJU Int. 2004 Jun;93(9):1344-8
references.pmid: 15180635
references.citation: Glia. 2007 Dec;55(16):1648-55
references.pmid: 17849469
references.citation: J Neurosci. 2001 Apr 1;21(7):2215-23
references.pmid: 11264297
references.citation: Curr Top Med Chem. 2004;4(16):1707-17
references.pmid: 15579103
references.citation: Brain Res Bull. 2003 Apr 15;60(1-2):93-104
references.pmid: 12725897
references.citation: Nat Med. 2004 Aug;10(8):821-7
references.pmid: 15258577
references.citation: J Cell Physiol. 1984 May;119(2):211-9
references.pmid: 6715419
references.citation: Nature. 2006 Aug 3;442(7102):527-32
references.pmid: 16885977
references.citation: Eur J Pharmacol. 1999 Jul 2;376(1-2):127-38
references.pmid: 10440098
references.citation: Physiol Rev. 2002 Oct;82(4):1013-67
references.pmid: 12270951
references.citation: Jpn J Pharmacol. 1998 Oct;78(2):113-45
references.pmid: 9829617
references.citation: Neuroscience. 2007 Jun 8;146(4):1817-28
references.pmid: 17478048
references.citation: J Immunol. 2002 Jun 15;168(12):6436-45
references.pmid: 12055263
references.citation: Nat Rev Drug Discov. 2008 Jul;7(7):575-90
references.pmid: 18591979
references.citation: J Med Chem. 2006 Jun 15;49(12):3659-66
references.pmid: 16759108
references.citation: J Biol Chem. 2000 Sep 15;275(37):29107-12
references.pmid: 10869366
references.citation: Int Rev Cytol. 2004;240:31-304
references.pmid: 15548415
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1999 Feb;359(2):102-9
references.pmid: 10048594
references.citation: Nature. 1994 Oct 6;371(6497):516-9
references.pmid: 7523951
references.citation: J Biol Chem. 2007 Dec 28;282(52):37350-8
references.pmid: 17962183
references.citation: Am J Physiol Renal Physiol. 2004 Nov;287(5):F1084-91
references.pmid: 15251862
references.citation: J Neurosci. 2008 Oct 29;28(44):11263-8
references.pmid: 18971468
references.citation: EMBO J. 2006 Nov 1;25(21):5071-82
references.pmid: 17036048
references.citation: Biochim Biophys Acta. 1992 Feb 19;1134(1):31-45
references.pmid: 1311958
references.citation: Br J Pharmacol. 2000 Jul;130(6):1418-24
references.pmid: 10903985
references.citation: J Neurosci. 2006 Feb 1;26(5):1378-85
references.pmid: 16452661
references.citation: J Neurosci. 1999 Jan 15;19(2):520-8
references.pmid: 9880572
references.citation: Biochem Biophys Res Commun. 1989 Dec 29;165(3):1279-85
references.pmid: 2610693
references.citation: Br J Pharmacol. 1999 Nov;128(6):1199-206
references.pmid: 10578132
references.citation: Biochimie. 2000 Apr;82(4):289-302
references.pmid: 10865118
references.citation: Brain Res. 1997 Sep 26;769(2):281-6
references.pmid: 9374196
references.citation: Br J Pharmacol. 2006 Dec;149(7):880-7
references.pmid: 17031385
references.citation: J Neurosci. 2004 Jul 14;24(28):6307-14
references.pmid: 15254086
references.citation: J Neurosci. 2008 Sep 10;28(37):9133-44
references.pmid: 18784294
references.citation: Mol Pain. 2009 Apr 23;5:20
references.pmid: 19389225
references.citation: Curr Med Chem. 2007;14(14):1505-23
references.pmid: 17584060
references.citation: Br J Pharmacol. 1998 Jul;124(6):1314-20
references.pmid: 9720806
references.citation: J Immunol. 2008 Jun 1;180(11):7147-57
references.pmid: 18490713
references.citation: J Biol Chem. 1990 May 5;265(13):7424-31
references.pmid: 1692021
references.citation: J Cereb Blood Flow Metab. 1996 Nov;16(6):1137-42
references.pmid: 8898685
references.citation: J Pharmacol Exp Ther. 2001 Mar;296(3):947-57
references.pmid: 11181928
references.citation: Trans Am Clin Climatol Assoc. 2007;118:199-208
references.pmid: 18528503
references.citation: J Neuropathol Exp Neurol. 2006 Nov;65(11):1090-7
references.pmid: 17086106
references.citation: J Neurosci. 2001 Sep 15;21(18):7135-42
references.pmid: 11549724
references.citation: Clin Exp Hypertens. 1999 May;21(4):299-332
references.pmid: 10369378
references.citation: Clin Exp Immunol. 2007 Jun;148(3):469-77
references.pmid: 17493019
references.citation: Nat Neurosci. 2005 Jun;8(6):752-8
references.pmid: 15895084
references.citation: J Immunol. 2006 Mar 1;176(5):3115-26
references.pmid: 16493071
references.citation: Mol Pharmacol. 1998 Jul;54(1):22-32
references.pmid: 9658186
references.citation: J Cell Biol. 1997 Sep 8;138(5):987-98
references.pmid: 9281578
references.citation: Neurochem Res. 2001 Sep;26(8-9):959-69
references.pmid: 11699948
references.citation: J Biol Chem. 2003 Apr 11;278(15):13309-17
references.pmid: 12551918
references.citation: Purinergic Signal. 2009 Mar;5(1):63-73
references.pmid: 18568426
references.citation: Purinergic Signal. 2007 Sep;3(4):389-98
references.pmid: 18404452
references.citation: Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):61-71
references.pmid: 18336732
references.citation: Neuroscience. 2001;102(3):593-602
references.pmid: 11226696
references.citation: J Neuropathol Exp Neurol. 2004 Jul;63(7):686-99
references.pmid: 15290894
references.citation: Pain. 2005 Apr;114(3):386-396
references.pmid: 15777864
references.citation: Biochem Biophys Res Commun. 2008 Dec 19;377(3):803-8
references.pmid: 18938136
references.citation: Pharmacol Ther. 2006 Jan;109(1-2):210-26
references.pmid: 16169595
references.citation: J Physiol. 1998 May 1;508 ( Pt 3):703-20
references.pmid: 9518727
references.citation: J Physiol. 1999 Apr 1;516 ( Pt 1):179-90
references.pmid: 10066932
references.citation: Brain Res Mol Brain Res. 2003 Aug 19;116(1-2):168-75
references.pmid: 12941474
references.citation: Nature. 1988 Aug 25;334(6184):698-700
references.pmid: 3137474
references.citation: Eur J Neurosci. 2006 May;23(10):2824-8
references.pmid: 16817887
references.citation: Neuroreport. 2001 Aug 28;12(12):2619-22
references.pmid: 11522936
references.citation: Analyst. 2001 Aug;126(8):1257-60
references.pmid: 11534589
references.citation: Am J Physiol. 1993 Sep;265(3 Pt 1):C577-606
references.pmid: 8214015
references.citation: Invest Ophthalmol Vis Sci. 2004 Mar;45(3):1026-32
references.pmid: 14985326
references.citation: J Vet Med Sci. 2001 Apr;63(4):367-72
references.pmid: 11346169
references.citation: Am J Respir Crit Care Med. 2009 Feb 15;179(4):265-70
references.pmid: 19201928
references.citation: J Pharmacol Exp Ther. 2008 Dec;327(3):620-33
references.pmid: 18772321
references.citation: J Clin Invest. 2003 Feb;111(3):371-9
references.pmid: 12569163
references.citation: Brain Res. 2001 Oct 12;915(2):248-55
references.pmid: 11595216
references.citation: Mol Neurobiol. 2008 Oct;38(2):123-8
references.pmid: 18704769
references.citation: Behav Brain Res. 2009 Dec 1;204(1):77-81
references.pmid: 19464323
references.citation: Arch Biochem Biophys. 1993 Aug 15;305(1):54-60
references.pmid: 7688203